SCHEMBL6093483

SCHEMBL6093483

COCCNc1ccc(NC(=O)c2c[nH]c3c2C(=O)CCC3)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.43
DGAT1 O75907 1/20 0.42
BUB1 O43683 2/20 0.41
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HAT1 O14929 1/20 0.38
EP300 Q09472 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ADRA1A P35348 3/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
KIT P10721 1/20 0.36
BRAF P15056 1/20 0.36
MAPK1 P28482 1/20 0.36
IKBKB O14920 1/20 0.36
FGFR4 P22455 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092075 0.90 HCAR3 (0.40) HCAR3BUB1ALDH1A1MEN1KMT2A
SCHEMBL6095310 0.89 HCAR3 (0.42) HCAR3ALDH1A1MAPTNPSR1HSD17B10
SCHEMBL6093288 0.88 ROCK2 (0.39) HCAR3BUB1ALDH1A1MEN1KMT2A
SCHEMBL6095908 0.86 HCAR3 (0.41) HCAR3BUB1ALDH1A1MEN1KMT2A
SCHEMBL6093985 0.85 ROCK2 (0.35) BUB1MEN1KMT2AMAPTNPSR1
SCHEMBL6092785 0.85 KIT (0.41) BUB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6394774 0.85 ROCK2 (0.42) BUB1ALDH1A1MEN1KMT2AMAPT
SCHEMBL6093234 0.84 KMT2A (0.46) BUB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6092145 0.82 LCK (0.40)
SCHEMBL8584124 0.82 KMT2A (0.45) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109351-B1 Fused pyrrolecarboxamides; GABA brain receptor ligands NEUROGEN CORPORATION (US) 2006-09-19 US disclosed
US-20050014939-A1 Fused pyrrolecarboxamides: GABA brain receptor ligands NEUROGEN CORPORATION 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014939-A1 Fused pyrrolecarboxamides: GABA brain receptor ligands GABRB2, GABRB1, GABRB3 HCAR3 113/4885DGAT1 4386/4885BUB1 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.